fbpx

Galaxy Diagnostics

Go Beyond the Limits of Detection

Provider Portal
Blog

Amanda

by on

New Medical Education for Bartonella Species Infections

We are excited to announce that six bartonellosis modules presented by Galaxy Diagnostics' chief scientific officer, Dr. Ed Breitschwerdt are now available to healthcare providers. AAFP (American Academy of Family Physicians) CME credit is available for provides that complete each module. They are also open to the general public for viewing. The modules are presented [...]

by on

Discussing Lyme Disease Testing with your Provider

Testing for Lyme borreliosis can be a difficult subject for patients to approach their healthcare providers about. Educating yourself on topics to discuss beforehand may help facilitate a productive conversation regarding your symptoms and why you think testing for Lyme borreliosis is the next step. Research on Lyme borreliosis increasingly suggests that an early diagnosis [...]

by on

How Eye Doctors Diagnose Cat Scratch Disease (Bartonella)

Bartonella species infections are implicated in symptoms related to the structural, vascular (blood vessels), and neurological aspects of the eye. Here we present recent cases in which the latest eye imaging technology was used to confirm infection and explain why these findings are important for improving diagnosis of bartonellosis in individuals with symptomatic and asymptomatic [...]

by on

Dr. Breitschwerdt Talks Bartonella and Skin on ReachMD

Galaxy co-founder and chief scientific officer, Dr. Ed Breitschwerdt, sat down with Dr. Michael Greenberg at ReachMD to discuss what dermatologists should know about Bartonella species infections and the potential role of skin lesions in the diagnosis of bartonellosis. Research over the past 30 years has shown that Bartonella species infect a wide array of [...]

by on

Rare Disease Day 2021 – The Data We Can Collect Together

Rare Disease Day is February 28th. Rare diseases have specific legal definitions that are tied to support from various governmental programs around the world. Patient registries are a key part of the call for funding for rare diseases and are needed to advance the research on tick-borne diseases like Lyme borreliosis, bartonellosis, and babesiosis. What [...]

by on

What is an antibody titer?

Clinicians often rely on laboratory testing to find evidence of infections that may explain a patient’s symptoms and help guide treatment. Direct evidence may be a specific segment of DNA or a protein that confirms the presence of the target pathogen. Indirect evidence could be antibodies and other immune biomarkers that suggest recent or past [...]

Sign Up to Receive Blog Updates!